Related Experiment Video
Updated: Jun 13, 2025

Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes
Published on: September 27, 2018
Identification of Mycobacterium tuberculosis intracellular survival-related virulence factors via CRISPR-based
Weiyi Liu1, Yingchao Wang1, Jiayuan Zhao1
1Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Abstract:
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), remains a serious infectious disease posing significant global health challenges. A critical evolutionary feature of M.tb is its genome encoding a set of eukaryotic-like secretory proteins, which facilitate intracellular survival by manipulating host immune responses. However, the specific eukaryotic-like secretory proteins that facilitate M.tb intracellular survival and their regulatory mechanisms on host immunity remain uncharacterized. In this study, a mutant library comprising 137 potential eukaryotic-like secretory proteins was constructed using clustered regularly interspaced short palindromic repeats (CRISPR)-non-homologous end joining genome editing technology. Subsequently, macrophages were infected with the mutant library, and CRISPR sequencing enabled preliminary identification of virulence factors associated with bacterial intracellular persistence. To validate the screen, two genes (Rv0066c and Rv3139) exhibiting the most pronounced reduction in intracellular survival rates when mutated were selected for the construction of large-fragment knockout strains (ΔRv0066c and ΔRv3139). Subsequent macrophage infection assays reconfirmed the impaired intracellular survival of these two mutants. RNA-seq analysis was conducted to characterize host gene expression profiles during ΔRv0066c-infected macrophage interactions. RNA-seq analysis of macrophages infected with wild-type and ΔRv0066c strains identified 138 differentially expressed genes, with 75 upregulated and 63 downregulated in ΔRv0066c. Gene ontology clustering of these differentially expressed genes highlighted molecular functions related to chemokine binding, chemokine-mediated signaling pathways, Ras protein signal transduction, and calcineurin-mediated signaling. Collectively, this work established a potential eukaryotic-like secretory protein mutant library and identified two novel M.tb effectors governing intracellular survival, providing potential new targets for anti-TB drug development.
Importance:
Eukaryotic-like secretory proteins that subvert host immunity to enable intracellular persistence are a key evolutionary adaptation of Mycobacterium tuberculosis (M.tb). In this study, we established a mutant library targeting 137 potential eukaryotic-like secretory proteins through clustered regularly interspaced short palindromic repeats (CRISPR)-non-homologous end joining genome editing technology. The library was subjected to macrophage infection assays, and CRISPR sequencing enabled identification of M.tb persistence-associated virulence determinants. Validation screens highlighted two genes (Rv0066c and Rv3139) that displayed the most significant intracellular survival defects to generate large-fragment knockout strains (ΔRv0066c and ΔRv3139). Macrophage infection experiments reconfirmed the compromised intracellular viability of both mutants. RNA-seq profiling of ΔRv0066c-infected macrophages identified 138 differentially expressed genes, with functional enrichment in chemokine signaling, Ras protein signal transduction, and calcineurin-mediated signaling. To conclude, this study identified two novel M.tb effectors contributing to intracellular survival as potential new targets for anti-TB drug development.
Insights
Researchers identified two novel Mycobacterium tuberculosis (M.tb) secretory proteins, Rv0066c and Rv3139, crucial for bacterial survival within host macrophages. This discovery offers potential new targets for developing effective anti-tuberculosis drugs.
Area of Science:
- Microbiology and Immunology
- Molecular Biology
- Genetics
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), is a major global health concern.
- M.tb possesses eukaryotic-like secretory proteins that aid its intracellular survival by manipulating host immunity.
- The specific roles and regulatory mechanisms of these M.tb secretory proteins in host immune evasion are largely unknown.
Purpose of the Study:
- To identify specific eukaryotic-like secretory proteins essential for M.tb intracellular survival.
- To investigate the impact of these proteins on host immune responses.
- To discover novel M.tb virulence factors as potential anti-TB drug targets.
Main Methods:
- Construction of a mutant library targeting 137 potential M.tb eukaryotic-like secretory proteins using CRISPR-non-homologous end joining.
- Macrophage infection assays with the mutant library followed by CRISPR sequencing to identify virulence determinants.
- Validation of key genes (Rv0066c, Rv3139) via knockout strains and subsequent macrophage infection and RNA-seq analysis.
Main Results:
- Mutations in Rv0066c and Rv3139 significantly impaired M.tb's intracellular survival in macrophages.
- RNA-seq analysis of Rv0066c-mutant infected macrophages revealed 138 differentially expressed host genes.
- Enriched host gene functions included chemokine binding, signaling pathways, Ras protein signal transduction, and calcineurin-mediated signaling.
Conclusions:
- Rv0066c and Rv3139 are identified as novel M.tb effectors critical for intracellular persistence.
- These proteins play a role in modulating host immune responses, specifically chemokine and Ras/calcineurin signaling.
- The identified M.tb effectors represent promising new targets for the development of anti-tuberculosis therapies.
More Related Videos
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017